Lv3
220 积分 2025-01-07 加入
How oxygenation shapes immune responses: emerging roles for physioxia and pathological hypoxia
15天前
已完结
Reducing the antigen-independent toxicity of antibody-drug conjugates by minimizing their non-specific clearance through PEGylation
18天前
已完结
Lorlatinib in Tyrosine Kinase Inhibitor−Naive Advanced ROS1 -Positive Non−Small Cell Lung Cancer
27天前
已完结
A Direct-to-Patient Digital Health Program for Lung Cancer Screening
27天前
已完结
Current Controversies and Challenges in Non-Oncogene-Addicted Synchronous Oligometastatic Non-Small Cell Lung Cancer: A Review
27天前
已完结
Lung Cancer in Nonsmoking Individuals
27天前
已完结
Capturing the Magic Bullet: Pharmacokinetic Principles and Modeling of Antibody-Drug Conjugates
29天前
已完结
Advances in LAG3 cancer immunotherapeutics
1个月前
已完结
The current and emerging immunotherapy paradigm in small-cell lung cancer
1个月前
已完结
Phase II Study of Neoadjuvant Concurrent Chemo-immuno-radiation Therapy Followed by Surgery and Adjuvant Immunotherapy for Resectable Stage IIIA-B (Discrete N2) Non–small-cell Lung Cancer: SQUAT trial (WJOG 12119L)
1个月前
已完结
皖公网安备34019202002308
